Skip to content
Screener

CeriBell, Inc. CBLL Price / sales

Price / sales at other companies

IAR
Integra LifeSciencesIART
0.8×+0.3×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
6.6×-3.5×
iRadimed logo
iRadimedIRMD
14.3×+5.4×
Teladoc Health logo
Teladoc HealthTDOC
0.6×+0.1×
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
4.7×-2.7×
ICU Medical logo
ICU MedicalICUI
1.7×+0.3×

Other financials

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation

See full
Market cap$713.7M+50.8%
Enterprise value$702.95M+54.6%

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
Net margin-64.7%+0.9pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%—
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

market cap/total revenue=7.2×

Based on the most recent quarter.

The source filing: CeriBell, Inc.’s 10-Q, filed August 10, 2026. Open the filing →

Filed
Aug 10, 2026, 4:50 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342574

FAQ

What is CeriBell, Inc.'s price / sales?
CeriBell, Inc. (CBLL) reported price / sales of 7.2× in Q2 2026.
How has CeriBell, Inc.'s price / sales changed year-over-year?
CeriBell, Inc.'s price / sales decreased by 21.1% year-over-year, from 9.2× to 7.2×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about CeriBell, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude